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Abstract
Background: A central aim of Universal Health Coverage (UHC) is protection for all against the cost of illness. In a
low income country like Bangladesh the cost burden of health care in tertiary facilities is likely to be significant for
most citizens. This cost of an episode of illness is a relatively unexplored policy issue in Bangladesh. The objective
of this study was to estimate an outpatient’s total cost of illness as result of treatment in private and public
hospitals in Sylhet, Bangladesh.
Methods: The study used face to face interviews at three hospitals (one public and two private) to elicit cost data
from presenting outpatients. Other socio-economic and demographic data was also collected. A sample of 252
outpatients were randomly selected and interviewed. The total cost of outpatients comprises direct medical costs,
non-medical costs and the indirect costs of patients and caregivers. Indirect costs comprise travel and waiting times
and income losses associated with treatment.
Results: The costs of illness are significant for many of Bangladesh citizens. The direct costs are relatively minor
compared to the large indirect cost burden that illness places on households. These indirect costs are mainly the
result of time off work and foregone wages. Private hospital patients have higher average direct costs than public
hospital patients. However, average indirect costs are higher for public hospital patients than private hospital
patients by a factor of almost two. Total costs of outpatients are higher in public hospitals compared to private
hospitals regardless of patient’s income, gender, age or illness.
Conclusion: Overall, public hospital patients, who tend to be the poorest, bear a larger economic burden of illness
and treatment than relatively wealthier private hospital patients. The large economic impacts of illness need a public
policy response which at a minimum should include a national health insurance scheme as a matter of urgency.
Keywords: Total cost of outpatients, Direct cost, Indirect cost, Health care, Public vs private, Bangladesh
Background
The health of the people of Bangladesh has improved in
recent years. This is evidenced by reductions in infant
and child mortality rates, increased vaccination rates, in-
creased availability of birth control, reduction in cholera
prevalence and improved arsenic prevention [1]. Over
the past 20 years health care availability has increased as
has the cost of treatment. Individuals’ expenditure on
health care has increased as a result. Cost barriers how-
ever still prevent the poorest of the poor from accessing
health care [2]. According to the Bangladesh Bureau of
Statistics [3] in 2010, 15 % of sick people were not
treated due to their inability to pay for the (relatively)
high cost of health care. Detailed cost of illness studies
make a significant contribution to understanding the
differential cost burden of illness [4, 5].
Bangladesh has a mixed health care system with both
public and private providers of primary health care
and outpatient services through tertiary hospitals.
Bangladesh is a low income country and in the face of
inadequate public health care expenditure, health care
providers have adopted the pre-payment mechanism
where individuals must pay for treatment before receiv-
ing it. This is a barrier to health care because of the rela-
tively high costs involved [6, 7]. In low income countries
households spend up to 40 % of their incomes on health
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care, whereas that figure is less than 20 % for middle
and high income countries [8–11]. Thus the large finan-
cial burden of health care is borne by the poorest of
society [9–12].
A recent International Center for Diarrhoeal Disease
Research, Bangladesh (ICDDR’B) study revealed that
around 6.4 million or 4 % of people in Bangladesh get
poorer every year due to excessive health costs [13]. It
found that the poorest 20 % of the population spent
16.5 % of their household income on direct health care
costs, while the richest 20 % spent just 9.2 %. Out of
pocket health expenditure by households totaled 64 % of
direct costs with the rest coming from government and
other sources [13]. This is an unreasonable burden for
many households in a nation with an average per capita
income of just on $US1000 per year [3].
This current study aims to inform policy makers about
the costs, both direct and indirect, of outpatient treat-
ment in public and private hospitals in one city in
Bangladesh. Given low incomes the financial burden of
health care is beyond the means of many people. This
results in significant numbers of people receiving inad-
equate treatment for illnesses or worse receiving no
health care at all, due to the insurmountable financial
burden of its cost. The results of this study will inform
those organizations trying to achieve Universal Health
Coverage (UHC) in Bangladesh. The WHO (2010) de-
fines UHC as access to good quality health care services
where people do not suffer unreasonable financial hard-
ship to pay for them [7, 14–17]. Research on the cost of
illness is required to inform the development of appro-
priate social policies to improve access to essential
health services and break the vicious cycle between ill-
ness and poverty [10]. Therefore, an analysis of total
(direct and indirect) costs of outpatients in both the
public and private hospital sectors is extremely import-
ant. It will assist Bangladeshi policy makers to develop
alternative methods to protect individuals and house-
holds from the extreme and catastrophic financial bur-
den of illness and health care treatment and assist to
increase access to health care services.
The purpose of the study is to calculate the total cost
of illness for outpatients due to different types of
illnesses in public and private hospitals in Sylhet,
Bangladesh. This study defines the direct costs of treat-
ment (such as fees, medications) and indirect costs of
illness (such as travel time and loss of income) of outpa-
tients for different types of illness using established and
validated cost methodologies [4, 14].
Methods
Study area
The divisional city of Sylhet (a major city in north-
eastern Bangladesh) which is situated in north-eastern of
Bangladesh was purposefully selected (Fig. 1). As a
divisional city, people from surrounding areas also
received health care in Sylhet. The city was chosen as it
has one public and three private medical training col-
leges and public hospitals and many private primary
health care clinics [18]. Data were collected in 2011 via
face to face interviews with a total of 252 outpatients
from one public medical college (MAG Osmani Medical
College Hospital) and two private medical college hospi-
tals (Jalalabad Ragib Rabeya Medical College and
Hospital and the Women’s Medical College and
Hospital) (Fig. 2).
Participants, procedures and ethical clearance
Patients were randomly selected and interviewed imme-
diately after their consultation. A serial number was
assigned to each patient before their consultation and
patients were randomly chosen. The random sample of
patients avoided sample selection bias and also any po-
tential identification problem. Enumerators waited out-
side the doctor’s office for the randomly assigned patient
to exit. Any patient who came for treatment was eligible
to take part in the study.
A structured questionnaire was administered to pa-
tients. This was designed to collect data including com-
ponents of direct medical and non-medical costs,
indirect costs, illness details and details of their socio-
economic status. The questionnaire is shown in
Additional file 1. These data were supplemented with
data from hospital staff on some direct costs and infor-
mal payments.
Enumerators provided some initial basic information
to patients about the study to get their agreement and
cooperation. No inducement, financial or otherwise, was
offered. Verbal informed consent was obtained before
proceeding with the interview. When the patient was a
child (below the age of 14) the accompanying adult
person answered the questionnaire. Ten enumerators
(university students) were trained to administer the
questionnaire.
The ethics committee of the Medical Faculty, Shahjalal
University of Science & Technology, approved the study,
reference number 570-2007/11.
Measuring the cost of Illness
The total cost of an outpatient’s illness includes direct,
indirect and intangible costs [19]. Direct costs are the
range of financial costs of health provider services,
medicines and other related observable costs. Indirect
costs are the monetary value of productive time losses to
the patient and other family members as a result of the
illness [10]. Intangible costs relate to suffering and grief
from illness and are not generally measurable due to
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Fig. 1 Region specified map of Bangladesh. Source: Banglapedia - National encyclopedia of Bangladesh 2011 (http://en.banglapedia.org/
index.php?title=Climate Accessed on 28th May 2016)
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their subjective nature [19, 20]. In this study, the intan-
gible costs of illness were not considered.
Direct costs
Direct costs includes medical and non-medical costs;
medical costs include diagnosis, registration fees, medi-
cations, diagnostics, continuing care, hospitalization,
rehabilitation; and non-medical costs are the costs of
transport to the hospital and any informal payments
[21, 22]. Informal payments are defined as a money
transfer from patient to hospital staff with the expec-
tation of quick or better treatment [23]. The informal
payments and medicine cost information were collected
from patients during the interview though those were not
included in the formal questionnaire. When the patient
spoke about informal payments (bribes) to hospital staff,
the enumerators asked about the amount and wrote it be-
side the related section. A similar method was employed
for the medicine costs. These payments were cross
checked with staff and the patient values were utilized in
the analysis.
Calculating the indirect costs of illness
Indirect costs of illness are those related to income or
productivity loss. This is the monetary value of a patient
or family caregiver’s income lost due to illness related
absences from work (both paid and unpaid) [21, 24].
Household’s loss of work time or productivity are
significantly affected by illness type [25]. These losses
can be valued from either the societal, individual/house-
hold or employer perspectives [26]. An individual/house-
hold perspective is adopted in this study.
There are different approaches to measuring total
productivity losses due to illness and most studies are
based on human capital theory. The human capital
approach or friction cost method estimates the value of
potential production losses (or income loss as a proxy)
as a consequence of illness [27–29]. Self-reported wage
rates have been used. Indirect cost was calculated for
both paid and unpaid work (care giving, household
activities). The income loss from foregone non-market
activities (unpaid work) was measured using occupation
specific wages [29].
Fig. 2 Sylhet City Map. Source: Google Maps 2016
Table 1 Respondents Characteristics
Public hospital
(N = 139)
Private hospital
(N = 113)
Mean Age (S.D) 33.55 (20.10) 33.76 (20.05)
Mean monthly
income (S.D)
BDT 10969 (9822) BDT 20252 (15108)
US$ 146.27 (130.96) US$ 270.03 (201.44)
Sex (Female) % 61 (43.9 %) 50 (44.2 %)
Living Location (Village) % 100 (71.9 %) 50 (44.2 %)
Note: 1US $ = 75 BDT as June 2011
Pavel et al. International Journal for Equity in Health  (2016) 15:167 Page 4 of 12
Data analysis
Data were analyzed using SPSS 20. All entries were
double checked. Independent-sample t tests and one-
way ANOVA tests were used to analyze if the outlined
differences in direct and indirect costs in public and
private hospitals were statistically significant. Costs were
presented as an average with a standard deviation in the
local currency, Bangladeshi Taka (BDT). US dollar (US$)
values were also reported using the exchange rate of
US$1 = 75 BDT obtained from the Central Bank of
Bangladesh during the mid-point of the data collection
year (2011).
Results
The objective of this study was to estimate patient’s total
cost (direct and indirect) of treatment and compare indi-
vidual cost components between private and public
hospitals in Bangladesh. This section outlines the cost
burden of disease by gender, age group, income quintile,
disease type, and treatment modality in both public and
private hospital.
Descriptive statistics
A total of 252 respondents participated in this study
with 139 attending the public hospital and 113 attending
the two private hospitals. The results in Table 1 present
descriptive statistics on respondent’s characteristics: the
mean age of respondents both in public and private hos-
pital were almost similar. The average monthly income
of public hospital respondents was half that of private
hospital respondents. This indicates a common bias of
higher income people obtaining health care from private
hospitals in preference to public hospitals. Villagers from
rural areas, who tend to be poorer than city dwellers go
to public hospitals more than the city dwellers and over-
all 72 % of public hospital respondents came from
villages.
Table 2 demonstrates that the average direct cost of
treatment for illness was marginally more for public
than for private hospital patients. Direct costs in both
were less than 4 % of overall total costs. The most sig-
nificant direct cost issue for public patients were average
transport costs and average informal payments which
were much higher than for private patients. Average in-
direct cost or patient’s income loss were the most signifi-
cant costs which in public hospital was 97 % of total
costs and 95 % in private hospital patients. Results from
Table 2 indicate that public hospital patients on average
paid more for their health care compared to private
hospital patients despite being poorer.
Table 2 Average cost of treatment by hospital type and treatment modality, BDT (US$)
Cost Parameters Public hospital (N = 139) Private hospital (N = 113)
Average cost
BDT ($US)
Standard deviation
BDT ($US)
Proportion of
total cost (%)
Average cost
BDT ($US)
Standard deviation
BDT ($US)
Proportion of
total cost (%)
Direct Medical Diagnostic 123 (1.65) 101 (1.35) 1.24 151 (2.02) 137 (1.83) 2.70
Medicine 29 (0.39) 21 (0.29) 0.29 28 (0.38) 5 (0.07) 0.50
Registration 21 (0.29) 19 (0.25) 0.22 37 (0.50) 34 (0.46) 0.67
Direct Non-medical Transport 73 (0.98) 57 (0.77) 0.74 43 (0.59) 32 (0.43) 0.78
Informal payment 31 (0.41) 31 (0.42) 0.31 8 (0.12) 14 (0.19) 0.15
Total Direct Cost 279 (3.72) 146 (1.95) 2.81 269 (3.59) 163 (2.18) 4.81
Indirect Cost Patient’s income loss 9643 (128.59) 9296 (123.95) 97.19 5338 (71.18) 6590 (87.87) 95.19
Total Cost of Treatment 9923 (132.31) 9335 (124.47) 100 5607 (74.77) 6562 (87.49) 100
Note: 1US $ = 75 BDT as at June 2011
Table 3 Average cost of treatment by income quintile, BDT (US$)
Income
quintile
BDT (US$)
Public hospital (N = 139) Private hospital (N = 113)
N Average direct cost Average indirect cost Average total cost N Average direct cost Average indirect cost Average total cost
<6212 (<82.82) 52 282 (3.76) 10683 (142.45) 10966 (146.21) 13 270 (3.61) 3763 (50.18) 4033 (53.78)
6212–12424
(82.82–165.65)
53 280 (3.74) 8658 (115.44) 8938 (119.18) 36 245 (3.27) 5134 (68.48) 5379 (71.73)
12425–18637
(165.66–248.49)
14 194 (2.59) 7980 (106.41) 8174 (108.99) 14 244 (3.26) 4898 (65.32) 5143 (68.57)
18638–24849
(248.50–331.32)
11 326 (4.35) 12059 (160.79) 12385 (165.14) 13 236 (3.16) 8564 (114.20) 8801 (117.36)
≥24850
(≥331.33)
9 327 (4.37) 9076 (121.03) 9404 (125.39) 37 313 (4.19) 5122 (68.301) 5436 (72.49)
Note: 1US $ = 75 BDT as at June 2011
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The analysis in Table 3 shows that the average total
costs for public hospital patients were higher than pri-
vate patients across all income quintiles. Costs for the
lowest income public patients were the second highest
of any income quintile, either public or private. That is,
those with the least capacity to pay are paying the high-
est costs of illness and treatment. Average indirect cost
analysis in Table 3 shows that patients treated in public
hospital paid more for their health care across all
income quintiles.
The total costs of treatment by age quintiles (Table 4)
show a similar pattern with public patients at all age
levels paying more than private hospital patients. Costs
rise in line with age in both cohorts. Average direct cost
was low compared to the average indirect cost for each
age quintile in both public and private hospitals. The
average direct cost analysis in Table 4 shows that pa-
tients treated in public hospital spend more money in
each age quintile except 60 plus age. The average indir-
ect cost analysis suggests that patients treated in public
hospital faced more income or productivity loss in each
age quintile than that of private hospital patients. From
the above discussion the total costs of illness were much
higher up to the third age quintile (36 to 60) for public
hospital’s patients but were higher for the last age
quintile (60 plus) for private hospital’s patients.
The losses associated with children illness and adult
care of them were significant as shown elsewhere [20].
In the public hospital the average total costs for males
and females were higher than for public hospital pa-
tients. The analysis in Table 5 shows that average total
costs of treatment for illness was higher in public hos-
pital (BDT 9923 or $132.31) than that of private hospital
(BDT 5607 or $74.77), regardless of patient’s gender but
average direct cost was higher for females in both public
and private hospitals. In addition, average indirect cost
was higher for both males and females patients in public
hospital.
Amongst children (under 14 years of age), analysis of
total cost of treatment for illness is presented in Table 6.
In public hospital the average total costs for male chil-
dren were higher than in private hospital. However, this
pattern was reversed for girl children treatment. How-
ever, for female children, total costs of illness in private
hospital were higher than public hospital. These differ-
entials may reflect the alternative attitudes towards girls
in poorer compared to richer households and their
potential future role as care givers to their parents.
Table 7 summarizes the total costs of illness by differ-
ent disease types and specialized hospital departments.
The average total costs do not have a consistent pattern
across public and private hospitals. In fact much hetero-
geneity is evidenced especially direct costs. As such the
results should be accepted but with caution. The analysis
in Table 7 indicates that the total costs of treatment by
illness varied across all hospital departments both in
public and private hospitals. The direct costs of treat-
ment for illness were higher in all hospital departments
in public hospital than private hospital except surgery,
gynecology, and orthopedics. Indirect costs of treatment
for illness was also higher for public hospital patients
except medicine, chest medicine, orthopedics, and
rheumatology departments compared to private hospital
patients.
The higher indirect costs in public hospital patients is
primarily explained by high travel and long waiting
times, especially compared to private hospital patients.
Public hospital patients spend on average almost double
the time accessing treatment which includes travel time
and waiting time at the hospital to see a doctor. Table 8
Table 4 Average cost of treatment by age group, BDT (US$)
Age group
(Years)
Public hospital (N = 139) Private hospital (N = 113)
N Average direct cost Average indirect cost Average total cost N Average direct cost Average indirect cost Average total cost
Up to 14 25 269 (3.60) 3993 (53.24) 4262 (56.84) 17 241 (3.22) 3768 (50.25) 4009 (53.46)
15 to 35 58 285 (3.81) 9699 (129.33) 9984 (133.13) 54 275 (3.67) 5137 (68.50) 5412 (72.17)
36 to 60 37 263 (3.51) 13367 (178.24) 13631 (181.75) 28 250 (3.34) 5444 (72.59) 5694 (75.93)
60 plus 19 303 (4.05) 9658 (128.77) 9961 (132.82) 14 320 (4.28) 7806 (104.08) 8126 (108.36)
Note: 1US $ = 75 BDT as at June 2011
Table 5 Cost of treatment by gender, BDT (US$)
Gender Public hospital (N = 139) Private hospital (N = 113)
N Average direct cost Average indirect cost Average total cost N Average direct cost Average indirect cost Average total cost
Male 78 263 (3.51) 10027 (133.70) 10290 (137.21) 63 242 (3.24) 6074 (81.00) 6317 (84.23)
Female 61 299 (3.99) 9153 (122.05) 9452 (126.04) 50 303 (4.04) 4410 (58.81) 4713 (62.85)
Total 139 279 (3.72) 9643 (128.59) 9923 (132.31) 113 269 (3.59) 5338 (71.18) 5607 (74.77)
Note: 1US $ = 75 BDT as at June 2011
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indicates that public hospital patients spend approxi-
mately double the time compared to private hospital pa-
tients. Most public hospital patients (71 %) were coming
from rural areas and their travel time and cost is higher
than that of patients who visited private hospitals who
mainly resided in the city. In public hospital the num-
bers of doctors were insufficient and there were always
long queues for treatment observed. Some of the public
hospital patients tried to jump the queue by offering
bribes to staff in an attempt to get to see the doctor
more quickly. In public hospital, 114 out of 139 patients
(82 %) paid money as informal payments to see the doc-
tor earlier. On the contrary, only 44 out of 113 patients
(38 %) paid money as informal payments to private
hospitals.
Some patients in both the public and private hospital
also expressed dissatisfaction about treatment and
wanted to change their current hospital to access better
treatment. The prevalence of this dissatisfaction was
higher in the public hospital. In the public hospital, 22 %
of patients were interested to change, compared to 8 %
among the private patients (Table 9).
Statistical analysis
Independent-sample t tests and one-way ANOVA tests
were used to analyze if the outlined differences in direct
and indirect costs in public and private hospitals were
statistically significant.
Table 10 shows the independent-samples t test results
of the group summary statistics of the total direct costs
and total indirect costs. For public hospital patients,
total direct medical costs and total indirect costs were
higher than for private hospital patients. This result is
antithetical to an equitable outcome for health care
given the income and wealth differentials.
In Table 11 the Levene’s Test for Equality of Variances
show that for total direct cost the outcomes are not
statistically significant. Further it can be concluded that
the means of total direct costs for public and private
hospital patients were not significantly different. The
mean difference was 0.129, and the p-value is 0.621
which indicates the absolute difference between the two
means is about 62 %.
The Levene’s Test for Equality of Variances for the
total indirect costs indicate statistical significance. This
result suggests that variances for the two groups, public
and private, were different. The mean difference was
31.06 which suggests that the difference in means is
statistically significantly different from zero.
Table 12 shows the results of the one way ANOVA to
test the homogeneity of variances for the total direct
and total indirect costs. The test assumes that the two
Table 6 Gender differential in cost of treatment among children
Gender Public hospital, BDT (US$) Private hospital, BDT (US$)
N Average direct cost Average indirect cost Average total cost N Average direct cost Average indirect cost Average total cost
Male 16 287 (3.83) 4995 (66.61) 5282 (70.44) 12 218 (2.92) 3422 (45.63) 3641 (48.55)
Female 9 238 (3.18) 2211 (29.48) 2449 (32.66) 5 294 (3.92) 4600 (61.33) 4894 (65.26)
Total 25 269 (3.60) 3993 (53.24) 4262 (56.84) 17 241 (3.22) 3768 (50.25) 4009 (53.46)
Note: 1US $ = 75 BDT as at June 2011
Table 7 Cost of treatment by department
Department
of hospital
Public hospital, BDT (US$) Private hospital, BDT (US$)
N Average direct
cost
Average indirect
cost
Average total
cost
N Average direct
cost
Average indirect
cost
Average total
cost
Surgery 11 279 (3.73) 11999 (159.99) 12278 (163.72) 2 738 (9.85) 6250 (83.33) 6988 (93.18)
Skin 8 261 (3.48) 7630 (101.74) 7891 (105.22) 11 164 (2.19) 3497 (46.63) 3661 (48.82)
Medicine 25 292 (3.90) 4806 (64.08) 5098 (67.98) 42 241 (3.22) 5510 (73.48) 5752 (76.69)
Ear, Nose and Throat 9 306 (4.09) 12921 (172.28) 13228 (176.38) 2 285 (3.81) 250 (3.33) 535 (7.14)
Neurology 8 259 (3.46) 9455 (126.07) 9715 (129.54) 5 244 (3.26) 1460 (19.47) 1704 (22.73)
Gynecology 16 345 (4.61) 11630 (155.08) 11976 (159.69) 11 555 (7.41) 2022 (26.97) 2578 (34.38)
Cardiology 20 321 (4.29) 11963 (159.51) 12284 (163.80) 6 265 (3.54) 8431 (112.41) 8696 (115.96)
Chest Medicine 4 303 (4.04) 10838 (144.51) 11141 (148.55) 3 200 (2.68) 11550 (154.01) 11751 (156.69)
Orthopedics 19 178 (2.38) 13444 (179.26) 13622 (181.64) 1 211 (2.82) 24000 (320.00) 24211 (322.82)
Rheumatology 2 267 (3.57) 3150 (42.00) 3417 (45.57) 5 255 (3.40) 6293 (83.91) 6548 (87.31)
Others (Non-specific) 17 258 (3.45) 6171 (82.29) 6430 (85.74) 25 218 (2.91) 600 (80.02) 6219 (82.93)
Note: 1US $ = 75 BDT as at June 2011
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variances are the same, that is, H0: σ
2
public = σ
2
private. For
total direct cost it failed to reject H0 implying that there
was little evidence that the variances were not equal and
the homogeneity of variance assumption may be reason-
ably satisfied. On the contrary, for total indirect cost H0
is rejected implying that there was evidence that the
variances were equal and the homogeneity of variance
assumption may not be reasonably satisfied.
Table 13 shows the output of the one way ANOVA
analysis indicating whether there were significant differ-
ences between group means. The results on total direct
medical cost shows that there was no statistically signifi-
cant difference between public and private hospital pa-
tient groups. On the contrary, the one way ANOVA on
total indirect medical cost shows there was a statistically
significant difference between public and private hospital
patient groups.
Table 14 shows the results of the Robust Test of
Equality of Means, which has been conducted using the
Welch and Brown-Forsythe method. The result of the
total direct medical costs show that there was no statisti-
cally significant difference between public and private
hospital patient groups. On the contrary, the Welch and
Brown-Forsythe test on total indirect medical costs
show that there was a statistically significant difference
between public and private hospital patient groups.
Discussion
The purpose of this study was to examine the direct and
indirect costs of outpatient treatment for different types
of illnesses in public and private hospitals in Sylhet,
Bangladesh. The direct costs of treatment make up only
a small part of the total costs of treatment. However,
these direct (monetary) costs are a large burden in the
context of extremely low incomes particular for public
hospital patients. The majority of the costs however are
indirect which are primarily income losses of patients
and their caregivers due to illness. The indirect costs are
over 95 % for both public and private outpatients of total
costs of illness.
Among the individual features: age, gender and disease
differences have an effect on the direct, indirect and
total costs of illness, whilst outpatients age 60 and over
experience the highest direct cost of illness. The average
direct cost for female outpatients is higher than male
outpatients both in public and private hospitals. The loss
of income to parents due to a children illness was sig-
nificant. Amongst child outpatients female children’s
average direct cost is also higher than that of male chil-
dren in private hospital. Old age patients and females
are more vulnerable and negatively affected by fees and
associated direct spending for treatment. The divergent
social roles assigned to women, men and older people
affects accessibility and control over resources and
decision-making needed to protect health. This results
in inequitable patterns of health services especially when
the cost of treatment is higher for women (cost of
gynecology is higher any other department) and old age
people. Health service delivery should strive for equity,
therefore, age and gender sensitive service delivery
should be effectively addressed by innovative health
policies.
Overall public hospital outpatients experience higher
total costs than those treated in private hospital. This is
significant and the causes and consequences are shown
in Fig. 3. Poverty is the main problem of public hospital
outpatients. The relatively high cost of health care ser-
vices reduces its demand, but not the need for the health
care. Usually the poorest outpatients waited the longest
to consult a doctor. This is problematic when their con-
ditions have already deteriorated as a result of delaying
treatment and the associated financial cost. Medications
that are provided in public hospitals are meant to be
“free” but are often unavailable. Moreover, poor outpa-
tients regularly substitute doctor care with the local
pharmacy owners’ opinion. This can be dangerous be-
cause those sellers rarely have any formal education in
medicine or pharmaceuticals. Further, the pharmaceut-
ical supply chain in developing countries like Bangladesh
are fraught with various problems and put treatments at
risk [30]. As a result of these issues, the morbidity of the
poor frequently becomes complicated and increases the
duration of treatment. This study recommends that
Table 8 Travel and waiting time for treatment
Hospital type N Average time spent (minutes)
Travel Time Waiting Time Total Time
Public Hospital 139 75.59 72.71 148.30
Private Hospital 113 44.14 38.11 82.25
Table 9 Dissatisfaction with treatment received
Treated in public
hospital and moved to
another hospital to
receive better treatment
Treated in private
hospital and moved
to another hospital to
receive better treatment
Number of
dissatisfied
patients
31 out of 139 (22.3 %) 9 out of 113 (8 %)
Table 10 Independent-sample t test summary statistics
Nature of the
health care
N Mean Std.
deviation
Std. error
mean
Total Direct Medical
Cost in USD
Public 139 3.722 1.950 0.165
Private 113 3.593 2.180 0.205
Total Indirect
Cost in USD
Public 139 128.585 123.955 10.513
Private 113 71.176 87.868 8.265
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more attention be paid to the costs of medication. It is
apparent that the present technology infrastructure of
Bangladesh’s pharmaceutical companies are not suffi-
ciently developed, moreover there is a lack of adequate
research funding [31] which contribute to inaccessibility
to medications.
Transport costs were the second most expensive direct
cost of treatment for illness in both public and private
hospitals. Villagers from rural areas were especially hard
hit by high fuel prices and high associated transport
costs, with this situation potentially limiting access to
hospital health care facilities which are mostly located in
towns and cities. This results in a significant welfare loss
for rural and poor villagers seeking health care services.
There is a role for government to play to ensure incen-
tives are made available for doctors to relocate to pri-
mary health care centers based in rural areas. Otherwise,
villagers will be adversely affected by high transport
costs which results in inaccessibility to health services.
Income reductions caused by illness were very large.
The majority of costs were indirect costs or loss of
income from illness which was 97 % of the total cost for
public patients and 95 % for private patients. These
income losses were catastrophic with the economic
burden varying little between illness morbidity and treat-
ment modality. It has been recently observed elsewhere
in a cost of cholera study in Bangladesh that indirect
costs were over 75 % of total costs of illness [32]. These
significant indirect costs of illness are routinely ignored
by the health system and government.
Hidden and informal payments in public hospitals are
widespread due to the long waiting times and poor man-
agement. Efficient functioning of any health system espe-
cially public hospitals which are frequently the only
supply option for health care for the poor should not be
dependent on bribery.
The public hospital quality of care was considered
inferior compared to private hospitals due to the lack of
an efficient and effective operating environment in pub-
lic hospitals. This was manifested through informal pay-
ments, long waiting times and staff indifference and
negligence. Policy makers should initiate behavioural
training into the professional development programme
for all of public health employees.
Other problems include the limited government health
care budget, hospital management power and lack of
information for consumers. Government has in recent
times initiated some health care information services
through mobile phones [33] but access to information is
still uncertain due to the relatively high cost of mobile
phones for the poorest. Budget limitations, hospital mis-
management and a lack of human resources combine to
further disadvantage poorer patients.
In the context of trying to achieve UHC whereby
people do not suffer unreasonable financial hardship to
pay for access to good quality health care services then a
functioning and efficient insurance market for health
care should be a major policy goal. Sadly this is far from
the reality in Bangladesh. In this study only 10 patients
(3.98 %) out of 252 patients had health insurance. Direct
‘out of pocket’ household expenditure accounts for an
Table 11 Independent-sample t test analysis
Levene’s test
for equality of
variances
t-test for equality of means
F Sig. t df Sig.
(2-tailed)
Mean
difference
Std. Error
difference
95 % Confidence
interval of the difference
Lower Upper
Total Direct Medical
Cost in USD
Equal variances assumed 0.020 0.889 0.496 250 0.621 0.129 0.260 −0.383 0.642
Equal variances not assumed 0.490 227.084 0.625 0.129 0.263 −0.390 0.648
Total Indirect Cost in USD Equal variances assumed 20.687 0.000 4.148 250 0.000 57.408 13.840 30.149 84.668
Equal variances not assumed 4.293 245.672 0.000 57.408 13.374 31.066 83.751
Table 12 One way ANOVA test - test of homogeneity of
variances
Levene statistic df1 df2 Sig.
Total Direct Medical Cost in USD 0.020 1 250 0.889
Total Indirect Cost in USD 20.687 1 250 0.000
Table 13 One Way ANOVA Test Analysis
Sum of
squares
df Mean
square
F Sig.
Total Direct
Medical Cost
in USD
Between
Groups
1.039 1 1.039 0.246 0.621
Within
Groups
1057.296 250 4.229
Total 1058.335 251
Total Indirect
Cost in USD
Between
Groups
205422.193 1 205422.193 17.204 0.000
Within
Groups
2985107.360 250 11940.429
Total 3190529.553 251
Pavel et al. International Journal for Equity in Health  (2016) 15:167 Page 9 of 12
estimated 60 % of total spending on health care [34],
with the remaining 40 % covered by public health care
services [35]. These numbers strengthen the argument
for health insurance.
Community based health insurance schemes have been
initiated on a pilot basis in the past few years by non-
government organizations. These have been fragmented,
local and not successful mainly due to relatively high
costs and low incomes. An investigation of micro health
insurance systems within a public-private partnership
should be undertaken. In 2007 the Ministry of Health
and Family Welfare initiated a maternal health voucher
to reduce the financial barriers to access to health care
in pregnancy. The scheme did not attract any new pro-
viders into the market though increased satisfaction of
public patients was expressed as a result of the higher
level of services that the voucher system induced [36].
Given the extremely low incomes and relatively large
out of pocket payments for health care there are strong
equity arguments for the development of a central gov-
ernment health care financing model which incorporates
health insurance.
There is strong evidence that health insurance pro-
vides financial protection by reducing ‘out of pocket’
spending. This study recommends health policy makers
examine the establishment of a national health care in-
surance scheme which will provide protection from the
catastrophic financial impacts of illness. Further, it has
been shown elsewhere that universal health insurance
supplemented by private insurance is successful in off-
setting large informal payments [23].
Study limitations
This study has several limitations - small sample sizes,
non-representative sample (covering only one metropol-
itan area) and selection bias of patients between public
and private hospitals.
The small sample size makes it difficult to find signifi-
cant statistical relationships using advanced statistical
methods, given these require larger sample sizes to
ensure a representative sample of the population. The
study is a snapshot of the city of Sylhet which may or
may not be representative of health care delivery in
other cities and towns in Bangladesh. Patient selection
of either public or private hospitals could potentially bias
the observed results, however several statistical tests
were conducted to examine the extent of potential bias.
The poor in Bangladesh borrow money or sell house-
hold assets as their primary coping strategy to pay for
the costs of treatment for illness [37]. This study did not
consider the impact of high interest payments on bor-
rowing money to pay for the cost of treatment for poor
people. The implication is that the total cost of treat-
ment is underestimated. In a few cases adult patients
were accompanying by other adult family members, but
the costs of these persons were not included in the cost
calculations which again might underestimate the total
cost of illness episodes.
Conclusion
This study compared the total costs of treatment for ill-
ness between public and private hospitals in Bangladesh.
It utilized different cost components (direct and indir-
ect) and found that the total costs of outpatient
Table 14 One Way ANOVA Test - Robust Test of Equality of
Means
Statistica df1 df2 Sig.
Total Direct Medical
Cost in USD
Welch 0.240 1 227.084 0.625
Brown-Forsythe 0.240 1 227.084 0.625
Total Indirect
Cost in USD
Welch 18.426 1 245.672 0.000
Brown-Forsythe 18.426 1 245.672 0.000
aAsymptotically F distributed
Fig. 3 Causes and consequences of public hospital outpatients higher cost
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treatment for illness were higher in the public sector
compared to the private sector. Illness causes high indir-
ect costs, and it was found that indirect costs comprised
more than 90 % of total overall costs in both the public
and private hospitals. This issue of very high indirect
costs is important in a relatively poor country like
Bangladesh. In the public sector, pro-poor policies such
as ‘free medication’, and ‘low registration fees’ are very
ineffective in reality to protect households from the
financial burdens of illness. These policies cannot pro-
tect households from the large indirect costs of illness
such as wage losses from long waiting times, the issue of
informal payments to achieve better and/or quicker
treatment and the low quality of health care services
provided. Further policy actions to address these issues
is urgently needed to stop and reverse the devastating
financial effect of ill health and its treatment on the
majority of Bangladesh citizens. Future research effort is
needed to focus on equity issues associated with illness.
A comprehensive national health insurance scheme
should be investigated as a matter of urgency.
Additional file
Additional file 1: Questionnaire. (PDF 209 kb)
Availability of data and materials
The datasets generated are not publically available due to SUST regulations
but are available from the corresponding author on a de-identified basis on
reasonable request.
Authors’ contributions
MSP coordinated data collection, analysis and interpretation of data, and
wrote the manuscript draft. SC contributed to the design and idea of the
study, as well as the analysis and interpretation of data and manuscript
revision. JG contributed to development of the concept and manuscript
construction, revision, editing and structure. All authors have approved the
final manuscript.
Competing interests
The authors declare that they have no competing interests.
Financial support
The field work for data collection was financially supported by Shahjalal
University of Science and Technology (SUST), Sylhet, Bangladesh. This
research study received no specific funding from any public, commercial or
non-profit organisation.
Author details
1Department of Economics, Shahjalal University of Science & Technology,
Sylhet 3114, Bangladesh. 2Institute for Resilient Regions (IRR), University of
Southern Queensland, Springfield 4300, QLD, Australia. 3School of
Commerce, University of Southern Queensland, Toowoomba 4350, QLD,
Australia. 4School of Accounting, Economics and Finance, University of
KwaZulu-Natal, Durban 4000, South Africa.
Received: 13 December 2015 Accepted: 3 October 2016
References
1. Chowdhury AMR, Bhuiya A, et al. The Bangladesh paradox: exceptional
health achievement despite economic poverty. Lancet. 2013;382(9906):
1734–45.
2. Sauerborn R, Adams A, Hien M. Household strategies to cope with the
economic costs of illness. Soc Sci Med. 1996;43(3):291–301.
3. Bangladesh Bureau of Statistics. Household Income and Expenditure Survey
Report 2010. Statistics and Informatics Division, Ministry of Planning, Government
of Bangladesh (GoB), 2014. http://www.bbs.gov.bd/WebTestApplication/userfiles/
Image/LatestReports/HIES-10.pdf. Accessed 4 Nov 2015.
4. Sakdapolrak P, Seyler T, Ergler C. Burden of direct and indirect cost of illness:
empirical findings from slum settlements in Chennai. South India Progr
Develop Studies. 2013;13(2):135–51.
5. Rice DP. Cost of illness studies: what is good about them? Injury Prevent.
2000;6:177–9.
6. Xu K, Evans DB, et al. Protecting household from catastrophic health
spending. Health Affairs. 2007;26(4):972–83.
7. The World Health Organization (WHO). World Health Report: Health System
Financing- The Path to Universal Coverage. Geneva, Switzerland, 2010.
http://www.who.int/whr/2010/10_summary_en.pdf. Accessed 4 Nov 2015.
8. The World Health Organization (WHO). The world health report-health
system: improving performance. Geneva, Switzerland, 2000. http://www.
who.int/whr/2000/en/. Accessed 4 Nov 2015.
9. Russell S. The economic burden of illness for households in developing
countries: a review of studies focusing on Malaria, Tuberculosis, and Human
Immunodeficiency virus/ acquired immunodeficiency syndrome. Am J Trop
Med Hyg. 2004;71(2):147–55.
10. McIntyre D, Thiede M, et al. What are the economic consequences for
households of illness and of paying for health care in low- and middle-
income country contexts? Soc Sci Med. 2006;62(4):858–65.
11. Chuma J, Gilson L, Molyneux C. Treatment-seeking behaviour, cost burdens
and coping strategies among rural and urban household in Coastal Kenya:
an equity analysis. Trop Med Int Health. 2007;12(5):673–86.
12. van Doorslaer EV, O’Donnell O, et al. Paying out-of-pocket for health care in
Asia: catastrophic and poverty impact. Working paper No. 2. 2005. EQUITAP
Project. http://www.eldis.org/go/home&id=24169&type=Document#.
Vga7vxKqqko. Accessed 4 Nov 2015.
13. Huda T, Khan JAM, et al. Monitoring and evaluating progress towards
Universal Health Coverage in Bangladesh. PLoS Med. 2014;11(9):e1001722.
14. Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol
Hepatol. 2014;20(4):327–37.
15. Giedion U, Alfonso EA, Díaz Y. The impact of universal coverage schemes in
the developing world: A review of the existing evidence. UNICO Studies
Series No. 25. Washington DC: World Bank; 2013. http://documents.
worldbank.org/curated/en/2013/01/17291221/impact-universal-coverage-
schemes-developing-world-review-existing-evidence. Accessed 4 Nov 2015.
16. Bitran R. Explicit health guarantees for Chileans: The AUGE benefits package.
UNICO Studies Series No. 21. Washington DC: World Bank; 2013. http://
documents.worldbank.org/curated/en/2013/01/17207311/explicit-health-
guarantees-chileans-auge-benefits-package. Accessed 4 Nov 2015.
17. Torres FM. Costa Rica case study: Primary health care achievements and
challenges within the frame of the social health insurance. UNICO Studies
Series No. 14. Washington DC: World Bank; 2013. http://documents.
worldbank.org/curated/en/2013/01/17207456/costa-rica-case-study-primary-
health-care-achievements-challenges-within-framework-social-health-
insurance. Accessed 4 Nov 2015.
18. Pavel MS, Chakrabarty S, Gow J. Assessing willingness to pay for healthcare
quality improvements. BMC Health Serv Res. 2015;15:43.
19. Byford S, Torgerson DJ, Raftery J. Cost of illness studies. BMJ. 2000;320(7245):
1335. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1127320/. Accessed 4
Nov 2015.
20. Chima RI, Goodman CA, et al. The economic impact of malaria in Africa: a
critical review of the evidence. Heal Pol. 2003;63(1):17–36.
21. Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current
practices and procedures. Heal Soc. 1982;60(3):429–62.
22. Gold MR, Siegel JE, et al. Cost-effectiveness in health and medicine. New
York: Oxford University Press; 1996.
23. Balabanova D, McKee M. Understanding informal payments for health care:
the example of Bulgaria. Heal Pol. 2002;62(3):243–73.
24. Goossens MEJB, Mölken MPMH, et al. The cost diary: a method to measure
direct and indirect costs in cost-effectiveness research. J Clin Epidemiol.
2000;53(7):688–95.
25. Babu BV, Nayak AN, et al. The economic loss due to treatment costs and
work loss to individuals with chronic lymphatic filariasis in rural
communities of Orissa. India Acta Tropica. 2002;82(1):31–8.
Pavel et al. International Journal for Equity in Health  (2016) 15:167 Page 11 of 12
26. Boccuzzi SJ. In: Weintraub WS, editor. Indirect health care costs. Chapter in
Cardiovascular Health Care Economics. New York: Springer; 2003. p. 63–79.
27. Woolley H, Mushkin SJ, et al. Cost of disease and illness in the United States
in the year 2000. Pub Heal Rep. 1978;93(5):493–588.
28. Koopmanschap MA, Rutten FFH, et al. The friction cost method for
measuring indirect costs of disease. J Heal Econ. 1995;14(2):171–89.
29. Poulos C, Riewpaiboon A, et al. Costs of illness due to endemic cholera.
Epidemiol Infect. 2011;140(3):500–9.
30. Yadav P. Health product supply chains in developing countries: diagnosis of
the root causes of underperformance and an agenda for reform. Heal Syst
Reform. 2015;1(2):142–54.
31. Pavel MS. Bangladesh pharmaceutical industry won’t be ready to
implement TRIPS by 2016. Dhaka: The Financial Express; 2012. http://print.
thefinancialexpress-bd.com/old/more.php?news_id=130487&date=2012-05-
23. Accessed 28 May 2016.
32. Sarker AR, Islam Z, et al. Cost of illness for cholera in a high risk urban area
in Bangladesh: an analysis from household perspective. BMC Infect Dis.
2013;13:518.
33. Directorate General of Health Services (DGHS): Health services through
mobile phone. Dhaka, Bangladesh 2015. Available at: http://www.dghs.gov.
bd/index.php/en/e-health/our-ehealth-eservices/84-english-root/ehealth-
eservice/105-health-service-through-mobile-phone. Accessed 4 Nov 2015.
34. Griffin CC. Health care in Asia. A comparative study of cost and financing.
World Bank regional and sectoral studies. Washington: The World Bank;
1992.
35. Desmet M, Chowdhury AQ, Islam MK. The potential for social mobilisation
in Bangladesh: the organisation and functioning of two health insurance
schemes. Soc Sci Med. 1999;48:925–38.
36. Ahmed S, Khan M. A maternal health voucher scheme: what have we
learned from the demand side financing scheme in Bangladesh? Heal Pol
Plan. 2011;26:25–32.
37. Adams AM. Charting a course through the jungle of urban healthcare
delivery in Bangladesh. Health System Global (HSG) 2016. http://www.
healthsystemsglobal.org/blog/112/Charting-a-Course-Through-the-Jungle-of-
Urban-Healthcare-Delivery-in-Bangladesh.html. Accessed 28 May 2016.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Pavel et al. International Journal for Equity in Health  (2016) 15:167 Page 12 of 12
